Taking 1gummy/day helps: Reduce hyperpigmentation by 36.84%
Depression patients exhibit kynurenine pathway metabolic imbalance, manifested as a reduced KYNA/QUIN ratio, suggesting that neurotoxic metabolites predominate (Savitz, 2020)
Research has demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles
#Pharmacy #DrugSafety #CDSCO #PatientSafety #Pharmacovigilance #EvidenceBasedMedicine #Healthcare #RegulatoryAffairs #FixedDoseCombination #PublicHealth #PharmaProfessionals To view or add a comment, sign in Regulatory Update: Ban on Fixed-Dose Combination (FDC) Medicines in India The Ministry of Health & Family Welfare, Government of India, in coordination with the Central Drugs Standard Control Organisation (CDSCO), has prohibited 16 Fixed-Dose Combination (FDC) medicines with immediate effect (June 2026)
Microdosing Tirzepatide involves using lower doses of the medication with a focus on supporting longevity rather than solely managing blood sugar or driving significant weight loss
Participants lost an average of 17.1% body weight at 48 weeks
